Graphic of a fountain pen writing on a piece of paper

PhRMA’s submission to the Trade Policy Staff Committee of the Executive Office of the President for inclusion in the 2020 National Trade Estimate (NTE) Report outlines the principal trade barriers biopharmaceutical companies face worldwide and identifies concrete actions the U.S. government can take to address these obstacles.

Graphic of a fountain pen writing on a piece of paper

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.